About Biological Industries
Biological Industries is a Healthcare company based in Cromwell (United States) founded in 1982, and was acquired by Sartorius in December 2019. Cell culture media development and manufacturing services. Biological Industries has raised $11 million across 1 funding round from investors including Sartorius and Fortissimo Capital. The company has 5 employees. Biological Industries offers products and services including Octet® R2, Ambr® 15 Cell Culture, Cell Culture Media, Flexsafe® Pro Mixer, and iQue® Platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is BIOLOGICAL INDUSTRIES USA INC. Its competitors include BioLife Solutions, RoosterBio and OriGene; 2 of its 3 listed competitors have raised funding.
Company details
Biological Industries was founded in 1982 and is based in Cromwell, United States. Services are offered to the life science sector, with emphasis on cell culture media development and manufacturing. The portfolio includes classical media, supplements, and reagents for stem cell research and cell therapy, as well as serum-free options for animal cell culture and molecular biology. A U.S. division was established in Connecticut in 2015 to support operations.
- Headquarters Cromwell, United States
- Employees 5
- Stage Acquired
- SectorsHealthcare
- Website bioind.com
- Social LinkedIn Facebook
- Acquired by Sartorius (Dec 2019)
- Legal Name Biological Industries Usa Inc
Products & Services of Biological Industries
Biological Industries offers a comprehensive portfolio of products and services, including Octet® R2, Ambr® 15 Cell Culture, Cell Culture Media, Flexsafe® Pro Mixer, and iQue® Platform.
Device for biolayer interferometry to analyze molecular interactions
Multi-parallel system for high-throughput cell culture processes
Specialty media for HEK293 and CHO cells in biopharmaceutical applications
Single-use mixer for liquid handling in bioprocessing
System for cytometry-based cell analysis in research
Funding Insights of Biological Industries
Biological Industries has successfully raised a total of $11M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $11 million completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11M
- Total Rounds 1
- Last Round Private Equity Round — $11M
- First Round $11M
(Apr 2017)
- Investors Count 1
All 1 funding rounds of Biological Industries with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2017 | $11M | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Biological Industries
Biological Industries has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Sartorius and Fortissimo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ffcapital.com | ||||
Laboratory and biopharmaceutical equipment is developed for production processes. | 1870 | sartorius.com | Gottingen, Germany |
Investor details for Biological Industries
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biological Industries
3 dated milestones of Biological Industries across 37 years, from founding to its latest funding, stage changes and deals.
- Founded Biological Industries is founded.
- Funding First funding round of $11.0M.
- Exit Acquired by Sartorius.
Competitors of Biological Industries
Biological Industries has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and OriGene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of Biological Industries
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biological Industries
Websites that share an audience with Biological Industries (bioind.com).
Websites whose visitors overlap most with Biological Industries. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bio-rad.com | 100% | 665.2K | #79,666 | View details | |
| biolegend.com | 87% | 229.6K | #142,656 | View details | |
| allelebiotech.com | 74% | 3.3K | #5,141,194 | View details | |
| encorbio.com | 71% | #3,038,138 | View details | ||
biochrom.de | biochrom.de | 68% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Biological Industries
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Biological Industries (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biological Industries
Complete news archive for Biological Industries
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biological Industries
Biological Industries was founded in 1982 and raised its 1st funding round 35 years after it was founded.
Biological Industries is headquartered in Cromwell, United States. It is registered at Cromwell, Connecticut, United States.
Biological Industries is a funded company, having raised a total of $11M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $11M, raised on Apr 2017.
Biological Industries has 5 employees.
Biological Industries was founded in 1982 and is based in Cromwell, United States. Services are offered to the life science sector, with emphasis on cell culture media development and manufacturing. The portfolio includes classical media, supplements, and reagents for stem cell research and cell therapy, as well as serum-free options for animal cell culture and molecular biology. A U.S. division was established in Connecticut in 2015 to support operations.
Biological Industries's top competitors include RoosterBio, BioLife Solutions and OriGene.
Biological Industries offers Octet® R2, Ambr® 15 Cell Culture, Cell Culture Media, Flexsafe® Pro Mixer, and iQue® Platform.
Biological Industries has 2 investors. Key investors include Sartorius, and Fortissimo Capital.
Biological Industries operates through Biological Industries Usa Inc.
Yes. Biological Industries was acquired by Sartorius in December 2019.

